Kara Carter

Kara Carter is an experienced professional in the field of antiviral research, currently serving as an Entrepreneur in Residence at Evotec since September 2021, where efforts are focused on providing therapeutics for viral diseases. Kara holds a position on the Board of Directors at Centauri Therapeutics Limited and has significant leadership experience, including roles as Immediate-Past President, President, and President-Elect of the International Society for Antiviral Research (ISAR) from June 2018 to May 2024. Previous positions include Executive Vice President and Senior Vice President of Discovery Biology at Dewpoint Therapeutics, as well as Executive Vice President and Senior Vice President of Infectious Disease at Evotec, showcasing a strong background in infectious disease research. Kara's earlier experience includes leading antiviral research at Sanofi and serving as a Senior Scientist at Praecis Pharmaceuticals. Education includes a PhD in Virology from the University of Chicago and a BA in Human Biology from Stanford University.